Valuation: Isodiol International Inc.

Market Cap 3.91M 2.77M 2.46M 2.28M 2.07M 262M 3.97M 27.38M 10.74M 137M 10.38M 10.16M 437M P/E 2018
-4.94x
P/E 2019 -0.37x
Enterprise Value 9.13M 6.46M 5.74M 5.32M 4.84M 613M 9.28M 63.95M 25.07M 320M 24.23M 23.72M 1.02B EV / Sales 2018
12.6x
EV / Sales 2019 2.48x
Free-Float
100%
Yield 2018 *
-
Yield 2019 -
1 month 0
Extreme 1.0E-6
0
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0.02
10 years 0
Extreme 1.0E-6
16.9
Manager TitleAgeSince
Chief Executive Officer - 23/05/2017
Corporate Officer/Principal - 29/08/2018
Director TitleAgeSince
Director/Board Member - 23/05/2017
Director/Board Member - 29/08/2018
Director/Board Member - 20/11/2018
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 128
-0.10%+6.59%+56.57%+107.01% 1,120B
-0.21%-2.25%+32.26%+67.33% 616B
+0.06%+3.24%+24.33%+91.20% 504B
+0.13%+5.11%+34.61%+58.69% 367B
+0.68%+0.24%+72.13%+43.10% 360B
-0.34%+3.32%+19.01%+46.24% 288B
-0.06%+2.58%-1.81%+17.62% 258B
-0.21%+4.25%+44.74%+52.51% 234B
+0.21%+3.32%+27.18%+96.05% 194B
Average +0.06%+2.98%+34.34%+64.42% 394.09B
Weighted average by Cap. -0.00%+3.52%+39.32%+74.39%

Financials

2018 2019
Net sales 19.14M 13.53M 12.03M 11.15M 10.14M 1.28B 19.44M 134M 52.53M 670M 50.77M 49.69M 2.14B 22.25M 15.73M 13.98M 12.96M 11.79M 1.49B 22.6M 156M 61.07M 779M 59.03M 57.77M 2.48B
Net income -36.02M -25.47M -22.64M -20.98M -19.09M -2.42B -36.6M -252M -98.88M -1.26B -95.57M -93.54M -4.02B -126M -89.01M -79.13M -73.34M -66.73M -8.45B -128M -882M -346M -4.41B -334M -327M -14.05B
Net Debt -15.55M -10.99M -9.77M -9.06M -8.24M -1.04B -15.8M -109M -42.68M -544M -41.26M -40.38M -1.74B 5.22M 3.69M 3.28M 3.04M 2.77M 350M 5.31M 36.56M 14.33M 183M 13.86M 13.56M 583M
Logo Isodiol International Inc.
Isodiol International Inc. is a Canada-based company, which is engaged in product development, sales, marketing, and distribution of hemp-based consumer packaged goods (CPG) and solutions. The Company supplies industrial hemp derivatives for medicinal formulations in the nutraceutical, cosmetic, and pharmaceutical markets. It grows and harvests hemp on an industrial scale, then processes and extracts cannabidiol (CBD) for distribution. It has commercialized naturally isolated CBD, including micro-encapsulations, and nanotechnology for consumables and topical skin care products. The Company's ready to label program offers a range of CBD products ready to be added or developed for various brands. The Company is focused on developing over-the-counter and pharmaceutical drugs and international expansion into Latin America, Asia, and Europe.
Employees
-
  1. Stock Market
  2. Stocks
  3. ISOLF Stock